JPY 2454.0
(1.95%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 47.58 Billion JPY | -3.73% |
2022 | 49.43 Billion JPY | -5.35% |
2021 | 52.22 Billion JPY | 4.5% |
2020 | 49.97 Billion JPY | 42.08% |
2019 | 35.17 Billion JPY | -1.7% |
2018 | 35.78 Billion JPY | 6.49% |
2017 | 33.6 Billion JPY | -6.52% |
2016 | 35.94 Billion JPY | -17.73% |
2015 | 43.69 Billion JPY | 96.73% |
2014 | 22.2 Billion JPY | -16.07% |
2013 | 26.46 Billion JPY | -14.41% |
2012 | 30.91 Billion JPY | -9.5% |
2011 | 34.16 Billion JPY | -4.38% |
2010 | 35.72 Billion JPY | 11.38% |
2009 | 32.07 Billion JPY | 52.52% |
2008 | 21.02 Billion JPY | 31.79% |
2007 | 15.95 Billion JPY | -4.9% |
2006 | 16.77 Billion JPY | 21.21% |
2005 | 13.84 Billion JPY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 44.4 Billion JPY | -6.68% |
2023 Q4 | 47.58 Billion JPY | -6.08% |
2023 Q3 | 50.66 Billion JPY | 0.21% |
2023 Q2 | 50.55 Billion JPY | -0.17% |
2023 FY | 47.58 Billion JPY | -3.73% |
2023 Q1 | 50.64 Billion JPY | 2.45% |
2022 Q3 | 51.76 Billion JPY | -4.23% |
2022 FY | 49.43 Billion JPY | -5.35% |
2022 Q4 | 49.43 Billion JPY | -4.51% |
2022 Q1 | 53.66 Billion JPY | 2.76% |
2022 Q2 | 54.05 Billion JPY | 0.71% |
2021 Q4 | 52.22 Billion JPY | -1.85% |
2021 Q1 | 51.51 Billion JPY | 3.08% |
2021 FY | 52.22 Billion JPY | 4.5% |
2021 Q3 | 53.21 Billion JPY | 3.3% |
2021 Q2 | 51.51 Billion JPY | 0.0% |
2020 Q2 | 39.71 Billion JPY | 0.03% |
2020 Q3 | 51.67 Billion JPY | 30.11% |
2020 Q4 | 49.97 Billion JPY | -3.28% |
2020 FY | 49.97 Billion JPY | 42.08% |
2020 Q1 | 39.7 Billion JPY | 12.87% |
2019 FY | 35.17 Billion JPY | -1.7% |
2019 Q4 | 35.17 Billion JPY | -6.6% |
2019 Q3 | 37.66 Billion JPY | 0.94% |
2019 Q2 | 37.3 Billion JPY | 0.22% |
2019 Q1 | 37.22 Billion JPY | 4.03% |
2018 Q2 | 34.5 Billion JPY | 3.9% |
2018 FY | 35.78 Billion JPY | 6.49% |
2018 Q1 | 33.2 Billion JPY | -1.18% |
2018 Q3 | 37.61 Billion JPY | 9.03% |
2018 Q4 | 35.78 Billion JPY | -4.87% |
2017 Q3 | 36.51 Billion JPY | -5.91% |
2017 Q1 | 37.01 Billion JPY | 2.97% |
2017 FY | 33.6 Billion JPY | -6.52% |
2017 Q4 | 33.6 Billion JPY | -7.98% |
2017 Q2 | 38.81 Billion JPY | 4.85% |
2016 FY | 35.94 Billion JPY | -17.73% |
2016 Q2 | 40.19 Billion JPY | -1.81% |
2016 Q1 | 40.93 Billion JPY | -6.3% |
2016 Q3 | 40.96 Billion JPY | 1.92% |
2016 Q4 | 35.94 Billion JPY | -12.26% |
2015 Q1 | 17.88 Billion JPY | -19.45% |
2015 FY | 43.69 Billion JPY | 96.73% |
2015 Q4 | 43.69 Billion JPY | -0.38% |
2015 Q3 | 43.85 Billion JPY | 4.21% |
2015 Q2 | 42.08 Billion JPY | 135.28% |
2014 Q4 | 22.2 Billion JPY | -2.23% |
2014 Q2 | 25.59 Billion JPY | 5.09% |
2014 Q3 | 22.71 Billion JPY | -11.26% |
2014 FY | 22.2 Billion JPY | -16.07% |
2014 Q1 | 24.35 Billion JPY | -7.94% |
2013 FY | 26.46 Billion JPY | -14.41% |
2013 Q1 | 27.91 Billion JPY | -9.7% |
2013 Q2 | 29.2 Billion JPY | 4.62% |
2013 Q3 | 30.96 Billion JPY | 6.01% |
2013 Q4 | 26.46 Billion JPY | -14.54% |
2012 Q1 | 35.08 Billion JPY | 2.71% |
2012 FY | 30.91 Billion JPY | -9.5% |
2012 Q4 | 30.91 Billion JPY | -10.39% |
2012 Q3 | 34.5 Billion JPY | 0.73% |
2012 Q2 | 34.25 Billion JPY | -2.39% |
2011 Q1 | 35.28 Billion JPY | -1.22% |
2011 Q2 | 35.06 Billion JPY | -0.62% |
2011 Q4 | 34.16 Billion JPY | -4.13% |
2011 FY | 34.16 Billion JPY | -4.38% |
2011 Q3 | 35.63 Billion JPY | 1.61% |
2010 Q3 | 36.91 Billion JPY | 1.64% |
2010 FY | 35.72 Billion JPY | 11.38% |
2010 Q2 | 36.31 Billion JPY | 15.77% |
2010 Q1 | 31.36 Billion JPY | -2.2% |
2010 Q4 | 35.72 Billion JPY | -3.21% |
2009 Q3 | 32.71 Billion JPY | -0.35% |
2009 Q4 | 32.07 Billion JPY | -1.97% |
2009 Q2 | 32.83 Billion JPY | 0.0% |
2009 FY | 32.07 Billion JPY | 52.52% |
2008 Q3 | 21.66 Billion JPY | 0.0% |
2008 Q4 | 21.02 Billion JPY | -2.94% |
2008 FY | 21.02 Billion JPY | 31.79% |
2007 FY | 15.95 Billion JPY | -4.9% |
2006 FY | 16.77 Billion JPY | 21.21% |
2005 FY | 13.84 Billion JPY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 16.89 Billion JPY | -181.723% |
Takeda Pharmaceutical Company Limited | 4843.75 Billion JPY | 99.018% |
Sumitomo Pharma Co., Ltd. | 418.88 Billion JPY | 88.64% |
Shionogi & Co., Ltd. | 11.62 Billion JPY | -309.517% |
Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -47235.503% |
Nippon Shinyaku Co., Ltd. | 2.87 Billion JPY | -1556.891% |
Kaken Pharmaceutical Co., Ltd. | 3.85 Billion JPY | -1135.998% |
Eisai Co., Ltd. | 206.74 Billion JPY | 76.983% |
Morishita Jintan Co., Ltd. | 425 Million JPY | -11096.684% |
Hisamitsu Pharmaceutical Co., Inc. | 2.1 Billion JPY | -2165.996% |
Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -12795.91% |
Fuso Pharmaceutical Industries,Ltd. | 12.72 Billion JPY | -274.044% |
Nippon Chemiphar Co., Ltd. | 16.98 Billion JPY | -180.23% |
Tsumura & Co. | 79.69 Billion JPY | 40.286% |
Kissei Pharmaceutical Co., Ltd. | 1.72 Billion JPY | -2655.409% |
Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -19402.421% |
Towa Pharmaceutical Co., Ltd. | 202.35 Billion JPY | 76.484% |
Fuji Pharma Co., Ltd. | 28.94 Billion JPY | -64.384% |
KYORIN Holdings, Inc. | 20.94 Billion JPY | -127.184% |
Taiko Pharmaceutical Co.,Ltd. | 3.8 Billion JPY | -1149.302% |
Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | -445.773% |
SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
MedRx Co., Ltd | - JPY | -Infinity% |
Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
Solasia Pharma K.K. | 60 Million JPY | -79209.847% |
Modalis Therapeutics Corporation | 412.5 Million JPY | -11435.978% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | -401.696% |
Sawai Group Holdings Co., Ltd. | 82.89 Billion JPY | 42.591% |
Cyfuse Biomedical K.K. | 913 Million JPY | -5112.038% |
Toho Holdings Co., Ltd. | 30.24 Billion JPY | -57.34% |
Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | -1584.285% |